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Introduction
Platelets play a key role in both initiation and propagation of acute coronary syndromes (ACS) (1, 2) . Mean platelet volume (MPV) is an important hematologic variable and indicator of platelet function (3, 4) . Larger platelets are more active and have higher thrombotic potential (5, 6) . They are also denser (7), have higher thromboxane A2 levels (8) , and express more glycoprotein Ib and IIb/IIIa receptors (9) , thus, larger platelets are aggregate more rapidly with collagen than smaller platelets (10) . In a recent trial, high MPV was found to be an independent predictor of ST-segment elevation myocardial infarction (STEMI) in young patients (11) .
Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) differs from STEMI with a pathophysiological background involving mainly platelets rather than the fibrin pathway (1) . Thus, platelets play a central role in the pathogenesis of NSTE-ACS.
Young persons with ACS display a unique risk profile compared with older patients (12, 13) . ACS are most frequently seen in older population; only a little part of acute coronary syndromes occurs among young population. Although its prevalence is increasing among young people, there are limited numbers of studies about the predictors of ACS in young patients (12, 13) .
In this regard, we hypothesized that an increased mean platelet volume predicts development of NSTE-ACS and we evaluated the MPV of young patients with NSTE-ACS and control subjects in this study.
Methods
Study design This is a retrospective observational study.
Study population
Overall, 79 patients, younger than 45 years old, with the diagnosis of NSTE-ACS (41 NSTEMI, 38 USAP) were included in the study. The control group was comprised of 45 subjects, who were younger than 45 years old with normal coronary arteries. All the NSTE-ACS patients had been hospitalized within the first 24 hour of their chest pain between May 2009 and February 2011. Only patients with the first acute coronary event were assessed. Permission for the study was obtained from local ethics committee of Abant İzzet Baysal University.
Data collection and definitions
Hospital medical records were retrospectively analyzed. Diagnosis of NSTEMI or USAP was made by assessing unstable chest pain, typical electrocardiographic changes and/or elevation of cardiac enzymes (1) . Also medical history, drug use, body mass index (BMI) and the other risk factors like diabetes mellitus, hypertension, hyperlipidemia, and cigarette smoking were recorded. Hypertension was diagnosed according to the Joint National Committee (JNC) 7 report as blood pressure above 140/90 mmHg or having anti-hypertensive therapy (14) . Diabetes mellitus was diagnosed as one of these criteria; Symptoms of diabetes plus any time plasma glucose concentration ≥200 mg/ dL, FPG ≥126 mg/dL, 2-h post load glucose ≥200 mg/dL (11.1 mmol/l) during an OGTT or active use of anti-diabetic treatment (15) Family history of CAD was diagnosed if patients had a first degree male relative under 55 years of age or a female relative less than 65 years of age with CAD (1). Patients who were smoking before hospitalization were accepted as smokers. Coronary angiography was performed by the Judkin's technique.
Laboratory analysis
Blood samples were obtained into blood collection tubes with ethylenediaminetetraacetic acid from all patients on admission in all cases. Hemoglobin, platelet count and MPV measurements were performed within approximately 60 minutes after blood sampling with Coulter LH 780 Analyzer and Coulter Hmx Hematology Analyzer (Beckman Coulter, Inc. CA, USA) with original method and reagents. LDL-C was calculated using the Friedewald formula. The other laboratory parameters were determined with standard methods.
Statistical analysis
Statistical analyses were performed the SPSS software version 15.0 (SPSS Inc. IL, USA). Continuous variables were presented as mean±standard deviation. Nominal variables were presented as the percentage. As the MPV was not normally distributed, shown by Kolmogorov-Smirnov test, Mann-Whitney U test was conducted in the comparison of MPV of NSTE-ACS and control group. The MPV values of the 3 groups (Control, USAP and NSTEMI) were compared with Kruskal-Wallis tests. The univariate analyses to identify variables associated with patient outcome (NSTE-ACS) was investigated using Chi-square, Fisher exact, Student's t and Mann-Whitney U tests, where appropriate. For the multivariate analysis, the possible factors identified with univariate analyses were further entered into logistic regression analysis to determine the independent pre- 
Results
Demographic, medical and biochemical characteristics of controls and patients with NSTE-ACS are shown in Table 1 . Hypertension, diabetes mellitus, smoking and family history were significantly higher in NSTE-ACS patients. In addition, high-density lipoprotein levels were significantly lower and triglycerides were significantly higher in NSTE-ACS patients. There was no difference in platelet counts between the groups (p=0.874).
The MPV was found to be significantly higher in the NSTE-ACS compared with control group (8.49±1.22 versus 7.78±0.65, p=0.001) (Fig. 1) (Fig. 1) .
According to the logistic regression analysis, male gender, smoking, body mass index and MPV were found to be independent predictors of NSTE-ACS ( Table 2 ). The fit of the developed model was tested using Hosmer-Lemeshow test. The p value of this test was found to be 0.28, meaning that the model had a high prediction value. Also, it was estimated that one unit increase in the MPV leads to 3.1 fold increased risk of NSTE-ACS.
Discussion
The main findings of the present study are; increased MPV was found to be an independent predictor of NSTE-ACS in young patients and MPV of the young patients with NSTE-ACS was found to be significantly higher than the MPV of the subjects of control group.
In acute coronary syndromes, a thrombogenic medium usually arises around the atherosclerotic plaque, and this can lead to adverse clinical outcomes. The thrombus formed on the disrupted endothelium can enlarge after plaque rupture or erosion. Platelet functions are very important, especially in the pathophysiology of arterial thrombosis. MPV is an important marker of platelet activity, which is measured as aggregation, vasoactive amine release, or the expression of specific receptors (16, 17) .
The metabolic and enzymatic activity of the platelets increase as the platelet volume increases (18) . The vasoactive mediators secreted by the platelets may contribute the inflammatory and atherogenesis process. So, increased risk of acute coronary syndromes in young patients with high MPV may be explained with the increased activity of platelets, increased inflammation and increased platelet aggregation (19 Many studies of MPV in ACS have been published. In one of them, MPV was found to be elevated in patients with STEMI (20) . In another, Pereg et al. (21) found an association between unsuccessful thrombolytic therapy and an increased MPV in patients with STEMI. Also, Chu et al. (22) reported an association between MPV and acute myocardial infarction in a recent meta-analysis. Further, they reported that MPV is related with MI mortality and restenosis. However, none of these studies evaluated patients with ACS who were younger than 45 years old. In our study, MPV was evaluated in young patients with NSTE-ACS. Thrombogenic activity is known to be higher in NSTE-ACS, and it has been shown to play an essential role in the etiopathogenesis of NSTE-ACS (1, 23) . Likewise, MPV were found to be higher in myocardial infarction patients with normal coronary arteries (24) . This supports that the acute coronary syndromes comprises on the basis of increased thrombogenic activity shown by high MPV, rather than atherosclerotic basis. In our study there was no acute coronary syndrome patient with normal coronary arteries.
In a study of premature atherosclerosis, Kurrelmeyer et al. (25) evaluated the role of sex differences in platelet function among subjects with a family history of premature coronary artery disease (CAD). They found that platelets from females were more reactive than platelets from males with a family history of premature CAD. In our study, the proportion of females was low in both the NSTE-ACS and control groups; moreover, the proportion of women was higher in the control group. Despite the possible increased platelet activity among females, MPV was found to be higher in the NSTE-ACS group in our study.
As expected, cardiovascular risk factors, including smoking, family history, hypertension, and diabetes mellitus, were more prevalent in young patients with NSTE-ACS than in the control group. Varol et al. (26) found that the serum MPV was significantly higher in regular smokers than in controls. Similarly, we found that the MPV in NSTE-ACS patients who smoked was higher than those in non-smoking NSTE-ACS patients. In another study, platelet activity was reported to decrease with advancing age (27) . This indicates that platelet activity is higher in young patients, as compared to older patients. The high MPV we found in young patients with NSTE-ACS may be associated with the increased level of platelet activity in this population. Therefore, MPV may be more important in premature atherosclerosis, and NSTE-ACS patients with a high MPV may be more prone to acute coronary events.
Study limitations
The major limitation of the study is the relatively low number of patients. In addition, MPV was evaluated only once; however, measurement of MPV after the acute phase could provide important data about the platelet functions and premature ACS.
Conclusion
In conclusion, MPV was found to be elevated in young patients with NSTE-ACS compared with control subjects. Also, increased MPV was found to be an independent predictor of NSTE-ACS. The platelet functions assessed by MPV may be more important in young patients with NSTE-ACS. Additional studies are needed to elucidate this relationship.
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